A new target for the treatment of endometriosis?

A new target for the treatment of endometriosis? By Dr. Youngran Park

Endometriosis affects around 10% of women in reproductive age, estimating more than 176 million women worldwide. Inflammation in the pelvic cavity is very common in endometriosis patients. Therefore, there are high concentrations of cytokines and immune cells in the peritoneal…

Key Points Lay Summary

The use of retinoic acid for the treatment of endometriosis

The use of retinoic acid for the treatment of endometriosis By Murat Osman

Endometriosis is one of the leading causes of chronic pelvic pain in women during their childbearing years. Several drugs have been researched to either reduce inflammation, decrease growth, or kill endometriotic cells. Retinoic acid (Vitamin A) is one such molecule…

Key Points Lay Summary

Retinoic Acid and Beclin1 Play an Opposite Role in Endometriosis Development

Retinoic Acid and Beclin1 Play an Opposite Role in Endometriosis Development By Kasthuri Nair

In their paper titled “Retinoic acid regulates endometriotic stromal cell growth through upregulation of Beclin1,” Lu et al. seek to elucidate the mechanism that drives endometriosis disease progression. Retinoic Acid (RA) is a vitamin A metabolite responsible for regulation of…

Key Points Lay Summary

Retinoic Acid Signaling Involved in Endometrial Decidualization

Retinoic Acid Signaling Involved in Endometrial Decidualization By Murat Osman

Decidualization occurs in the eutopic endometrium during the luteal phase and is controlled by signaling pathways such as cyclic adenosine monophosphate (cAMP) and progesterone. Researchers from the Northwestern University School of Medicine reported in their recent paper entitled "Altered Retinoid…

Key Points Lay Summary